<i>ERBB2</i> mutation is associated with a worse prognosis in patients with <i>CDH1</i> altered invasive lobular cancer of the breast
- DOI
- 10.18632/oncotarget.13019
- Published
- 2016-11-02
- Container
- Oncotarget
- Publisher
- Impact Journals, LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.18632/oncotarget.13019,
title = {<i>ERBB2</i> mutation is associated with a worse prognosis in patients with <i>CDH1</i> altered invasive lobular cancer of the breast},
author = {Zheng Ping and Gene P. Siegal and Shuko Harada and Isam-Eldin Eltoum and Mariam Youssef and Tiansheng Shen and Jianbo He and Yingjie Huang and Dongquan Chen and Yiping Li and Kirby I Bland and Helena R Chang and Dejun Shen},
year = {2016},
journal = {Oncotarget},
doi = {10.18632/oncotarget.13019},
url = {https://doi.org/10.18632/oncotarget.13019}
}RIS
TY - JOUR TI - <i>ERBB2</i> mutation is associated with a worse prognosis in patients with <i>CDH1</i> altered invasive lobular cancer of the breast AU - Zheng Ping AU - Gene P. Siegal AU - Shuko Harada AU - Isam-Eldin Eltoum AU - Mariam Youssef AU - Tiansheng Shen AU - Jianbo He AU - Yingjie Huang AU - Dongquan Chen AU - Yiping Li AU - Kirby I Bland AU - Helena R Chang AU - Dejun Shen PY - 2016 JO - Oncotarget DO - 10.18632/oncotarget.13019 UR - https://doi.org/10.18632/oncotarget.13019 ER -
APA
Ping, Z., Siegal, G. P., Harada, S., Eltoum, I., Youssef, M., Shen, T., He, J., Huang, Y., Chen, D., Li, Y., Bland, K. I., Chang, H. R., & Shen, D. (2016). <i>ERBB2</i> mutation is associated with a worse prognosis in patients with <i>CDH1</i> altered invasive lobular cancer of the breast. Oncotarget. https://doi.org/10.18632/oncotarget.13019
Source records
- crossref · retrieved 2026-09-27T03:33:38.842Z